• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Indian journal of physiology and pharmacology >Evaluation of Empirical Usage of Respiratory Medications in Treatment of Patients Presenting With Chronic Lower Respiratory Symptoms During Spirometric Screening
【24h】

Evaluation of Empirical Usage of Respiratory Medications in Treatment of Patients Presenting With Chronic Lower Respiratory Symptoms During Spirometric Screening

机译：血液筛查期间慢性降低呼吸道症状患者治疗呼吸药物的实证用法评价

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Background: An observational and cross-sectional study was done to evaluate the empirical use of medications in respiratory diseases in 550 urban patients aged 18-60 years (both gender) presenting with chronic lower respiratory symptoms (LRS) referred from OPDs to attend spirometry testing.Methods: After obtaining detailed clinical profile, patients were divided into two groups based on treatment history with respiratory medications: Treated [n=470] and Untreated [n=80] and Spirometry was carried out in each patient following recommendations of ATS/ERS (2005) at lung function laboratory, department of Physiology, RG, Kar Medical College and Hospital, Kolkata. Patients were categorized based on Spirometry variable FVC, FEV,, FEV/FVC.FEF and PEFR values.Results: It was found that empirical usage of medications without spirometry in patients with LRS is widespread with the possible future adverse outcome. Furthermore, under diagnosis, misdiagnosis, and over-diagnosis of obstructive lung diseases occurred significantly in clinical assessment as revealed by post-bronchodilator response (BDR) test.Conclusion: Present study concludes that all chronic lower respiratory symptoms patients should have their diagnoses confirmed with Spirometry analysis prior to receiving medications to avoid incorrect diagnosis as well as unwanted adverse effects.
机译：背景：进行了一个观察和横截面研究，以评估550名城市患者（两性）患有慢性呼吸道症状（LRS）的550岁的城市患者呼吸系统药物的实证使用，从OPDS提交肺活量测量测试.Methods：在获得详细的临床概况后，患者基于治疗史基分为两组，呼吸药物治疗历史：在每位患者中进行处理[n = 470]并在每个患者中进行未处理的[n = 80]，在ATS / ERS的建议下进行肺活量测定法（2005）在加尔各答，KAR医学院和医院生理学，RG，KAR医学院和医院肺功能实验室。患者基于Spirometry变量FVC，FEV，FEV / FVC.FEF和PEFR值进行分类此外，在支气管扩张剂反应（BDR）试验中透露的临床评估中诊断在接受药物之前的肺活量分析以避免错误诊断以及不希望的不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号